Literature DB >> 15990779

Short and long-term effects of cigarette smoking independently influence exhaled nitric oxide concentration in asthma.

Charles P McSharry1, Ian C McKay, Rekha Chaudhuri, Eric Livingston, Iona Fraser, Neil C Thomson.   

Abstract

BACKGROUND: The fractional concentration of nitric oxide in exhaled breath (FeNO) is elevated in asthma. FeNO measurement has been proposed as a noninvasive index of disease activity. Cigarette smoking suppresses FeNO, which limits its use in smokers.
OBJECTIVE: To identify and model short-term and long-term influences of cigarette smoking on FeNO.
METHODS: The smoking history, FeNO, and fractional concentration of carbon monoxide in exhaled breath (FeCO) were measured in 53 subjects with asthma and 51 control subjects. A mathematical model of the short-term and long-term effects of cigarette smoking on FeNO was derived.
RESULTS: Subjects with asthma had higher FeNO than controls ( P < .001). Smokers had increased FeCO ( P < .001). The short-term effect (hours since last cigarette) was associated with increased FeNO ( P < .01) and decreased FeCO ( P < .05). The long-term effect (years smoked) was associated with decreasing FeNO only in the subjects with asthma ( r = -0.62; P = .005). These short-term and long-term effects were independent and were combined in a model predicting FeNO, predicted log 10 FeNO = 1.23 - 0.58 e -0.34t - 0.00000103 x (lifetime cigarettes), where t = hours since the last cigarette. This gave a convincing prediction of FeNO ( r = 0.83; P < .0001).
CONCLUSION: Short-term and long-term effects of smoking influenced the measurement of FeNO. We defined a model that describes these effects. The use of this formula may improve the value of FeNO measurements in smokers with asthma.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15990779     DOI: 10.1016/j.jaci.2005.03.025

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  13 in total

Review 1.  Emerging molecular phenotypes of asthma.

Authors:  Anuradha Ray; Timothy B Oriss; Sally E Wenzel
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2014-10-17       Impact factor: 5.464

Review 2.  Exhaled nitric oxide measurements: clinical application and interpretation.

Authors:  D R Taylor; M W Pijnenburg; A D Smith; J C De Jongste
Journal:  Thorax       Date:  2006-09       Impact factor: 9.139

3.  Biomarkers in exhaled breath condensate: a review of collection, processing and analysis.

Authors:  N M Grob; M Aytekin; R A Dweik
Journal:  J Breath Res       Date:  2008-09-08       Impact factor: 3.262

4.  Utility of Exhaled Nitric Oxide Fraction for the Diagnosis of Hypersensitivity Pneumonitis.

Authors:  I Ojanguren; M J Cruz; A Villar; M Barrecheguren; F Morell; X Muñoz
Journal:  Lung       Date:  2015-11-13       Impact factor: 2.584

5.  Improvement of Airflow Limitation by Fluticasone Propionate/Salmeterol in Chronic Obstructive Pulmonary Disease: What is the Specific Marker?

Authors:  Keiichiro Akamatsu; Kazuto Matsunaga; Hisatoshi Sugiura; Akira Koarai; Tsunahiko Hirano; Yoshiaki Minakata; Masakazu Ichinose
Journal:  Front Pharmacol       Date:  2011-07-18       Impact factor: 5.810

6.  Environmental effects on fractional exhaled nitric oxide in allergic children.

Authors:  Stefania La Grutta; Giuliana Ferrante; Velia Malizia; Fabio Cibella; Giovanni Viegi
Journal:  J Allergy (Cairo)       Date:  2011-11-17

7.  Bronchodilator response and lung function decline: Associations with exhaled nitric oxide with regard to sex and smoking status.

Authors:  Elisabet Nerpin; Diogenes Seraphim Ferreira; Joost Weyler; Vivi Schlunnsen; Rain Jogi; Chantal Raherison Semjen; Thorainn Gislasson; Pascal Demoly; Joachim Heinrich; Dennis Nowak; Angelo Corsico; Simone Accordini; Alessandro Marcon; Giulia Squillacioti; Mario Olivieri; Rune Nielsen; Ane Johannessen; Francisco Gómez Real; Judith Garcia-Aymerich; Isabel Urrutia; Antonio Pereira-Vega; Jose Antonio Gullón; Anna-Carin Olin; Bertil Forsberg; Össur Ingi Emilsson; Isabelle Pin; Deborah Jarvis; Christer Janson; Andrei Malinovschi
Journal:  World Allergy Organ J       Date:  2021-05-18       Impact factor: 4.084

8.  Effects of Reduced Nicotine Content Cigarettes on Fractional Exhaled Nitric Oxide and Self-Reported Respiratory Health Outcomes Among Smokers With Psychiatric Conditions or Socioeconomic Disadvantage.

Authors:  Anthony C Oliver; Michael DeSarno; Charles G Irvin; David Kaminsky; Jennifer W Tidey; Stacey C Sigmon; Sarah H Heil; Diann E Gaalema; Dustin Lee; Janice Y Bunn; Danielle R Davis; Joanna M Streck; Thomas Gallagher; Stephen T Higgins
Journal:  Nicotine Tob Res       Date:  2022-01-01       Impact factor: 5.825

9.  Reproducibility of exhaled nitric oxide in smokers and non-smokers: relevance for longitudinal studies.

Authors:  Abraham Bohadana; Jean-Pierre Michaely; Dan Teculescu; Pascal Wild
Journal:  BMC Pulm Med       Date:  2008-02-28       Impact factor: 3.317

10.  F eNO-based asthma management results in faster improvement of airway hyperresponsiveness.

Authors:  Katrine Feldballe Bernholm; Anne-Sophie Homøe; Howraman Meteran; Camilla Bjørn Jensen; Celeste Porsbjerg; Vibeke Backer
Journal:  ERJ Open Res       Date:  2018-10-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.